RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers

In 2013 the European Medicine Agency (EMA) restricted the indication for anti-EGFR targeted therapy to metastatic colorectal cancer (mCRC) with a wild-type RAS gene, increasing the need for reliable RAS mutation testing. We evaluated the completeness and reproducibility of RAS-testing in the Netherl...

Descripción completa

Detalles Bibliográficos
Autores principales: Boleij, Annemarie, Tops, Bastiaan B.J., Rombout, Paul D.M., Dequeker, Elizabeth M., Ligtenberg, Marjolijn J.L., van Krieken, J. Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558179/
https://www.ncbi.nlm.nih.gov/pubmed/25944693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558179/
https://www.ncbi.nlm.nih.gov/pubmed/25944693

Ejemplares similares